‘Making it Meaningful’: Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services.

This study reports on the process of using an adapted Experienced-Based Co-Design (EBCD) conducted with culturally and linguistically diverse (CALD) consumers and cancer service staff to co-design the novel ‘Making it Meaningful’(MiM) instrument at a cancer service in Australia. Multi-source experiential and contextual information was gathered in phase 1 of the co-design and this evidence, coupled with knowledge gathered via a feedback event was used to inform three co-design workshops in phase 2. A series of meetings were conducted prior to and in between the workshops. Theory was progressively integrated into the workshop content. Two Mandarin speaking CALD consumers and three cancer service staff participated as co-design members. Workshops were supported by a multilingual fieldworker, co-facilitated by researchers and a consumer co-facilitator, and conducted using a hybrid model (face-to-face or online participation). In the first workshop members democratically selected to focus on a strategy to enable CALD consumers to make non-emergency urgent contact with the cancer service for medication related communication. The second workshop resulted in consensus to develop an accessible instrument that would identify appropriate contacts and information sources for medication management between appointments. In the third workshop, the prototype MiM instrument was developed and refined. The MiM is a novel instrument designed with CALD consumers to enhance their knowledge of medication management and empower them to contact cancer service staff about medication safety concerns. Feasibility testing is the next step with successful implementation requiring senior health leadership support and involvement of co-design members as change agents.
Related content
-
Quality & Clinical Excellence
Connecting Volunteers to Hospital Goals: An Inpatient Fall Prevention Program
Traditionally, volunteer programs focus on hours and the total number of volunteers, which misses the opportunity to show impact and a connection to hospital goals. In 2023, Mount Sinai Morningside’s goals focused on our values of flow, people, financial stewardship, and safety and quality. For safety and quality, the key performance indicator for 2023 was
Learn more -
Policy & Measurement | Quality & Clinical Excellence
PX Pulse: Consumer Perspectives on Patient Experience in the U.S. – June 2024
The latest release of PX Pulse reveals consumer perception of quality and experience remain stagnant from last quarter, both with lower than desired rankings. Cost continues to be top of mind for consumers, with the cost of premiums jumping from the third slot to the first as the most important item to consumers. Findings about
Learn more -
Culture & Leadership | Patient Family & Community Engagement | Quality & Clinical Excellence
Patient Advocacy Community Connection Call: Leader Rounding
This Patient Advocacy Community Connection Call focused on leader rounding as a follow-up to the webinar, Leader Rounding: A Proactive Approach to Improve Experience, held on October 10, 2023. *Please note: Calls do not provide patient experience education credit (PXE).
Learn more